Redwood AI

Redwood AI is a Canadian chemistry-technology company bridging the gap between computational design and physical manufacturing. While many artificial intelligence firms focus exclusively on early-stage molecular discovery, we specialize in the missing middle, the complex transition from a promising molecular concept to a scalable, synthesizable therapeutic product. Our mission is to make that transition faster, more predictable, and more efficient.

At the core of our work is a suite of proprietary AI architectures purpose-built for the chemical sciences. Rather than adapting generic machine learning tools, we develop models that understand the practical realities of synthetic chemistry and decision-making support tools for key considerations such as price and safety. Our platform transforms historical and experimental data into actionable route design, allowing pharmaceutical partners to predict reaction outcomes and optimize scale-up workflows before the first reagent is poured. This approach reduces experimental dead ends and accelerates movement from discovery chemistry into process development.

Redwood AI is focused on solving the friction between discovery and downstream manufacturing. By combining deep chemical domain expertise with advanced machine learning, we deliver practical capabilities that fit directly into existing research and development workflows:

■ Predictive Route Scouting: identifying efficient synthetic pathways to complex targets with fewer iterations.

■ Process Intensification: designing high-yield, low-waste routes that are viable at commercial scale.

■ Actionable Intelligence: producing interpretable model outputs that chemists can use on the bench to support confident Go or No-Go decisions.

Our technology is designed to integrate seamlessly with the infrastructure already used by pharmaceutical and biotechnology organizations. We emphasize reproducibility, traceability, and scientific transparency so that computational recommendations can be adopted with confidence in regulated environments. By embedding AI earlier in process development, we help partners shorten development timelines, lower manufacturing risk, and generate more robust intellectual property.

Redwood AI collaborates with global pharmaceutical companies, contract research organizations, academic research institutions and emerging biotech firms to translate innovative molecules into manufacturable medicines. The company operates at the intersection of software and laboratory science, delivering tools that complement human expertise rather than replace it. Our goal is to ensure that promising therapies do not stall because of synthetic complexity or scale-up uncertainty.

Based in Canada and focused globally, Redwood AI is building the next generation of chemical intelligence systems. By uniting advanced computation with real-world chemistry, we are shortening the distance between a promising molecule and a viable medicine, helping to bring safer and more affordable treatments to patients worldwide.